东曜药业股份有限公司（股票代码：01875）于2026年7月3日披露2026年6月股份变动月报表，报告期为截至2026年6月30日。
公告显示，东曜药业-B上月底已发行普通股为772,787,887股，当月无新增发行或回购注销，公司股本总数仍为772,787,887股，未持有任何库存股份。公告同时确认，截至报告期末，公司满足足够的公众持股量要求。
在股权激励方面，东曜药业-B披露，截至6月末，首发前购股权计划（行使价为0.286美元/股，约合2.2335港元/股）下，共有2万份已授出但未行使的股份期权，报告期内亦无新股因股权激励计划而发行或转让。
公司确认上述股份变动事项均严格依照香港联交所《上市规则》及相关法律法规执行。公告由联席公司秘书吕颖一签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.